CION Cancer Clinics
Adult T-cell leukaemia lymphoma and the HTLV-1 virus | CION Cancer Clinics
Adult T-cell leukaemia lymphoma (ATLL) is a rare blood cancer caused by long-term infection with the HTLV-1 virus. Most people who carry HTLV-1 never develop it. When ATLL does appear, usually decades later, it is one of four types, from slow smouldering disease to aggressive acute ATLL. The type guides treatment. This page explains the link, the types, treatment and what the family should consider. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
The short answer
How is HTLV-1 linked to adult T-cell leukaemia lymphoma?
Adult T-cell leukaemia lymphoma, or ATLL, is a rare blood cancer caused by long-term infection with a virus called HTLV-1. Most people who carry HTLV-1 never develop ATLL. In the few who do, it usually appears decades after the infection, and it can range from slow-growing to very aggressive.
What HTLV-1 is
HTLV-1, human T-cell lymphotropic virus type 1, is a virus that lives inside T cells, a type of white blood cell. It stays in the body for life. Most carriers feel completely well and do not know they have it. It is more common in Japan, the Caribbean, parts of South America, Africa and the Middle East, and it is found in India too.
How the virus leads to cancer
Over many years, the virus can change how infected T cells grow. In a small number of carriers, one of those cells begins to multiply out of control. That is ATLL. Doctors cannot yet predict well which carriers will develop it, which is why HTLV-1 carriers are sometimes followed up.
Why the diagnosis needs care
ATLL can look like other T-cell lymphomas or skin conditions. A positive HTLV-1 blood test, together with the lymphoma cells on a blood test or biopsy, confirms it. Your report may describe the cells as "flower cells" because of their shape.
ATLL can raise the calcium level in the blood quickly. Confusion, extreme thirst, passing a lot of urine, repeated vomiting, severe weakness or drowsiness need emergency care. Fever, breathlessness or a new cough during treatment can mean a serious infection. Go to the nearest emergency department now or call 108, and say the person has ATLL.
Not sure whether this applies to you?
Ask an oncologistFour types
Which type of ATLL is on the report?
ATLL is divided into four types. The type shapes almost every decision, from whether to treat now to how strongly.
Smouldering
Few abnormal cells in the blood, sometimes with skin or lung changes. It grows slowly and may be watched closely rather than treated at once. It can change into a faster type, so regular reviews still matter.
Chronic
A raised white cell count with abnormal cells, sometimes swollen lymph nodes or skin rash. Some chronic cases are slow, while others behave more aggressively.
Lymphoma type
Mainly swollen lymph nodes, with few abnormal cells in the blood. It is aggressive and needs prompt treatment, usually with combination chemotherapy, once scans and a biopsy have confirmed it.
Acute
The most aggressive type. Many abnormal cells in the blood, often high calcium, skin rash, and liver or spleen involvement.
Often comes with
- High calcium in the blood
- Serious infections
Side by side
Is being an HTLV-1 carrier the same as having ATLL?
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Treatment
How is ATLL treated?
Treatment depends mainly on the type. Slow types may be watched, or treated with antiviral medicines such as zidovudine combined with interferon. Aggressive types, the acute and lymphoma types, usually need combination chemotherapy started quickly.
Other options your team may discuss
Mogamulizumab, an antibody that targets a marker called CCR4 on ATLL cells, is used in some countries, though access in India may be limited. For fit people with aggressive ATLL who respond to first treatment, a donor stem cell transplant may offer longer control. CION's haematology team evaluates the case, presents it to a tumour board and, where a transplant is advised, coordinates referral to a qualified centre.
Who strong treatment may not suit
Intensive chemotherapy and donor transplant are hard on the body. They may not suit people with serious heart, kidney or lung problems, or those weakened by infections. Preventing infection is a large part of care, and preventive medicines are often prescribed.
What this page cannot tell you
It cannot tell you how the illness will behave in your family member or what the outlook is. The type, blood results and response to treatment shape that. Ask the haematologist to explain your own picture.
Commonly believed
What do families often worry about wrongly?
Most carriers never develop ATLL or any other illness from the virus. A positive test is a reason for follow-up with a doctor, not a diagnosis of cancer.
HTLV-1 does not spread through everyday contact, sharing meals, utensils, toilets or hugs. It passes through breast milk, sex, blood and shared needles.
Close family members, especially a partner and children, may benefit from testing. Sharing the diagnosis carefully, with a doctor's help, protects the people you love.
Antivirals are used mainly for slow types. Aggressive types usually need chemotherapy, and the virus itself stays in the body.
For the family
What should the rest of the family do?
-
Talk to the haematologist first
Ask who in the family should be tested. Usually this means a partner, children and the mother of the person with ATLL. Testing is a choice, and the doctor can talk through what a result would mean before anyone gives blood.
-
The blood test
A screening antibody test, confirmed by a second test if positive. Results should be explained by a doctor, not read alone.
-
If a woman tests positive
Discuss infant feeding with the doctor before a baby is born, because breastfeeding is a main way the virus passes to children.
-
Protecting partners
Condoms lower the chance of passing the virus through sex. Carriers should not donate blood, organs or breast milk.
-
Long-term follow-up
Carriers are sometimes offered occasional check-ups so any change is noticed early. Between visits, report a lasting skin rash, swollen glands, night sweats or repeated infections to a doctor, and mention the HTLV-1 result.
Questions we are asked
Common questions about ATLL and HTLV-1
How did my father get HTLV-1?
Most people with ATLL caught the virus many decades ago, often as a baby through breastfeeding, or later through sex or a blood transfusion. It is usually impossible to know exactly when. It is not a sign of anything he did wrong, and finding the source rarely changes treatment.
Is ATLL the same as HIV?
No. Both are viruses that infect immune cells and can spread in similar ways, but they are different viruses causing different illnesses. HTLV-1 does not cause AIDS. Doctors sometimes test for both, because the routes of spread overlap.
Can the virus be removed from the body?
Not at present. HTLV-1 stays in the body for life. Treatment aims to control ATLL, not to clear the virus. Research into vaccines and new antivirals continues, but nothing is available for routine use yet.
Why does he keep getting infections?
ATLL weakens the immune system, and treatment can weaken it further. Unusual infections of the lungs, skin and gut are common. The team often prescribes preventive medicines. Report fever, cough, breathlessness or loose motions early, and do not stop any prescribed medicine on your own.
Should my children be tested?
It is worth asking the haematologist. If the mother carries the virus, children who were breastfed may have been infected. A positive result in a child or adult means follow-up, not cancer. The doctor can explain what testing will and will not tell you.
Why is the skin rash part of the illness?
ATLL cells often travel to the skin, causing rashes, patches, lumps or ulcers. A skin biopsy may help with diagnosis. Some rashes are due to infection or treatment instead, so show any new skin change to the team rather than treating it with creams at home.
What does CION do for someone with ATLL?
CION's haematology team, led by Dr. Basudev Pokhrel, reviews the reports, confirms the type, presents the case at a tumour board and plans treatment. Where a transplant or a newer drug is needed, the team coordinates access with qualified centres.
Is treatment covered by Aarogyasri or insurance?
Chemotherapy for blood cancers is often covered under Aarogyasri, PM-JAY, CGHS, ECHS, EHS or cashless insurance, but newer drugs and transplant costs may be treated differently. Scheme rules change, so check your current cover. Call the helpline and the team will help.
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- World Health Organization — Human T-lymphotropic virus type 1
- National Cancer Institute — Adult Non-Hodgkin Lymphoma Treatment (PDQ) - Patient Version
- Leukemia & Lymphoma Society — Non-Hodgkin lymphoma
- Cancer Research UK — Types of non-Hodgkin lymphoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Not sure what to do next?
Tell us what has been found so far and we will help you reach the right specialist. One helpline serves every CION centre.